Haleon plc (ETR:H6D0)

Market Cap	38.97B -2.5%
Revenue (ttm)	12.85B -2.1%
Net Income	1.78B +39.9%
EPS	0.19 +41.6%
Shares Out	n/a
PE Ratio	21.95
Forward PE	19.36
Dividend	0.08 (1.81%)
Ex-Dividend Date	Aug 14, 2025

Volume	18,012
Average Volume	30,654
Open	4.305
Previous Close	4.316
Day's Range	4.305 - 4.380
52-Week Range	3.752 - 5.116
Beta	n/a
RSI	59.68
Earnings Date	Feb 25, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 24,561
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: H6D0

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.

Financial numbers in GBP